Therapeutic Options for Patients with Primary Refractory or Early Relapsed DLBCL
In this MEDtalk, Manali Kamdar gives her perspectives on current therapeutic options for patients with primary refractory and early relapsed diffuse large B-cell lymphoma. What are the options for the large group of patients that cannot be offered stem cell transplants?
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
